The Driving Force of the Na(+)/Ca(2+)-Exchanger during Metabolic Inhibition

por Baartscheer, Antonius, Schumacher, Cees A., Coronel, Ruben, Fiolet, Jan W. T.
Publicado 2011

Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na(+)/H(+) exchanger 1: persistent inhibition under various experimental conditions

por Zuurbier, Coert J, Baartscheer, Antonius, Schumacher, Cees A, Fiolet, Jan W T, Coronel, Ruben
Publicado 2021

Empagliflozin decreases myocardial cytoplasmic Na(+) through inhibition of the cardiac Na(+)/H(+) exchanger in rats and rabbits

por Baartscheer, Antonius, Schumacher, Cees A., Wüst, Rob C. I., Fiolet, Jan W. T., Stienen, Ger J. M., Coronel, Ruben, Zuurbier, Coert J.
Publicado 2016

Protease XIV abolishes NHE inhibition by empagliflozin in cardiac cells

por Chen, Sha, Schumacher, Cees A., Van Amersfoorth, Shirley C. M., Fiolet, Jan W. T., Baartscheer, Antonius, Veldkamp, Marieke W., Coronel, Ruben, Zuurbier, Coert J.
Publicado 2023

Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients

por Uthman, Laween, Baartscheer, Antonius, Schumacher, Cees A., Fiolet, Jan W. T., Kuschma, Marius C., Hollmann, Markus W., Coronel, Ruben, Weber, Nina C., Zuurbier, Coert J.
Publicado 2018

Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na(+)/H(+) exchanger, lowering of cytosolic Na(+) and vasodilation

por Uthman, Laween, Baartscheer, Antonius, Bleijlevens, Boris, Schumacher, Cees A., Fiolet, Jan W. T., Koeman, Anneke, Jancev, Milena, Hollmann, Markus W., Weber, Nina C., Coronel, Ruben, Zuurbier, Coert J.
Publicado 2017